Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids.
Biomed Pharmacother
; 144: 112357, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-34794234
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylpropionates
/
Pyrroles
/
Insulin Resistance
/
Lipid Metabolism
/
Fatty Liver
/
Diet, High-Fat
/
Fructose
/
Liver
/
Hypolipidemic Agents
/
Obesity
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Biomed Pharmacother
Year:
2021
Type:
Article
Affiliation country:
India